Technical Analysis for ARWR - Arrowhead Research Corporation

Grade Last Price % Change Price Change
B 64.93 1.99% 1.27
ARWR closed up 1.99 percent on Friday, September 17, 2021, on 2.65 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Flat
Historical ARWR trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Stochastic Reached Oversold Weakness 1.99%
Oversold Stochastic Weakness 1.99%
Pocket Pivot Bullish Swing Setup 2.24%
50 DMA Resistance Bearish 3.85%
Older End-of-Day Signals for ARWR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1% about 24 hours ago
60 Minute Opening Range Breakout about 24 hours ago
60 Minute Opening Range Breakdown 1 day ago
Down 1% 1 day ago
2x Volume Pace 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Arrowhead Research Corporation Description

Arrowhead Research Corporation operates as a clinical stage therapeutics company. It has development programs in oncology, obesity, and chronic hepatitis B virus (HBV) infection. The company assembles a set of technologies, including Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown in rodents and non-human primates, and induces endosomal escape; and RONDEL, a RNA delivery system for systemic siRNA delivery, and RNAi-mediated mRNA and protein knockdown in human melanoma patients. It also offers Homing Peptides platform, a library of short peptides for the development of peptide-drug conjugates and companion diagnostics. The company's principal product candidates include Adipotide, an anti-obesity peptide, which is in Phase I clinical trial for disrupting the blood supply that supports unhealthy fat by the targeted induction of apoptosis (cell death) in the vasculature of adipose tissue; ARC-520, an RNAi-based therapeutic to treat chronic HBV infection; and CALAA-01, an RNAi-based therapeutic that has completed a Phase IB clinical trial, which targets solid tumors. Its products also comprise CRLX-101 for NSC lung cancer; and Tubulin Inhibitor for oncology. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Solid Tumors Organ Systems Genetics Molecular Biology Infection Melanoma Gene Expression Hepatitis B Library Obesity Peptides Hepatitis B Virus Companion Diagnostic RNA Molecular Genetics Rna Interference Biochemistry Chronic Hepatitis B Virus Apoptosis Chronic Hepatitis B Small Interfering Rna

Is ARWR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 93.66
52 Week Low 41.6
Average Volume 569,360
200-Day Moving Average 72.91
50-Day Moving Average 64.74
20-Day Moving Average 64.94
10-Day Moving Average 64.78
Average True Range 2.35
ADX 13.77
+DI 19.19
-DI 20.68
Chandelier Exit (Long, 3 ATRs) 62.55
Chandelier Exit (Short, 3 ATRs) 65.18
Upper Bollinger Bands 69.36
Lower Bollinger Band 60.52
Percent B (%b) 0.5
BandWidth 13.61
MACD Line -0.27
MACD Signal Line -0.19
MACD Histogram -0.0811
Fundamentals Value
Market Cap 6.64 Billion
Num Shares 102 Million
EPS 0.09
Price-to-Earnings (P/E) Ratio 705.76
Price-to-Sales 73.24
Price-to-Book 14.24
PEG Ratio -1.32
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 68.53
Resistance 3 (R3) 68.16 66.58 67.93
Resistance 2 (R2) 66.58 65.67 66.77 67.73
Resistance 1 (R1) 65.76 65.10 66.17 66.13 67.53
Pivot Point 64.18 64.18 64.39 64.37 64.18
Support 1 (S1) 63.36 63.27 63.77 63.73 62.33
Support 2 (S2) 61.78 62.70 61.97 62.13
Support 3 (S3) 60.96 61.78 61.93
Support 4 (S4) 61.33